Pricing Log in Create free account

Akari Therapeutics PLC (AKTX) vs Kyntra Bio Inc (KYNB)

Akari Therapeutics PLC and Kyntra Bio Inc are both Biotechnology companies. Akari Therapeutics PLC and Kyntra Bio Inc are of similar size ($14.8M and $13.6M). Akari Therapeutics PLC has negative trailing earnings, so its P/E is not meaningful; Kyntra Bio Inc trades at 0.1×. Kyntra Bio Inc has the higher net margin (3,967.8% vs 0.00%) and the higher return on invested capital (0.00% vs −167.9%). Across the 13 metrics below, Kyntra Bio Inc leads on 8 and Akari Therapeutics PLC on 5.

Valuation

Metric AKTX KYNB Biotechnology median
P/E n/m 0.08 10.60
P/S n/m 3.37 9.40
P/B 0.77 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 15.46 9.02
Earnings yield (316.53%) 1,179.69% (32.88%)
Free cash flow yield (75.80%) (245.05%) (23.13%)

Profitability

Metric AKTX KYNB Biotechnology median
Gross margin 0.00% 6.28% 68.51%
Operating margin 0.00% (1,089.78%) 0.00%
Net margin 0.00% 3,967.77% 0.00%
Free cash flow margin 0.00% (824.19%) 0.00%
Return on equity (140.09%) (157.83%) (51.96%)
Return on assets (69.16%) 131.26% (46.06%)
Return on invested capital (167.93%) 0.00% 0.00%

Growth

Metric AKTX KYNB Biotechnology median
Revenue growth (TTM) — (37.15%) 6.76%
EPS growth (last fiscal year) 68.99% 478.08% 29.88%
Revenue growth, 5-year CAGR — (48.42%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AKTX KYNB Biotechnology median
Debt to equity 0.04 0.00 0.00
Current ratio 0.60 2.69 4.97
Net debt to EBITDA 0.27 1.97 1.01

Dividend

Metric AKTX KYNB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AKTX KYNB Biotechnology median
Market cap 13.56m 14.82m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack